|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61P 25/06 | |
| A61K 9/00 | |||
| A61K 31/4045 |
| (11) | Patento numeris | 2303392 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 08874746.4 |
| Europos patento paraiškos padavimo data | 2008-10-30 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-04-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-09-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2008/081841 |
| Data | 2008-10-30 |
| (87) | Numeris | WO 2009/154649 |
| Data | 2009-12-23 |
| (30) | Numeris | Data | Šalis |
| 142604 | 2008-06-19 | US |
| (72) |
SEBREE, Terri, B., US
PIERCE, Mark, US
O`NEILL, Carol, US
|
| (73) |
Teva Pharmaceuticals International GmbH,
Schlüsselstrasse 12, 8645 Rapperswil-Jona,
CH
|
| (54) | PHARMACOKINETICS OF IONTOPHORETIC SUMATRIPTAN ADMINISTRATION |
| PHARMACOKINETICS OF IONTOPHORETIC SUMATRIPTAN ADMINISTRATION |